BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 16, 2008
View Archived Issues
SVV-001 studied in experimental medulloblastoma in mice
Read More
Renovo presents results from Juvista and Zesteem trials
Read More
Rigel presents preclinical data on novel JAK2 inhibitor R-723
Read More
Qnexa meets primary endpoint in 28-week EQUATE study
Read More
Xoma provides preclinical animal data for diabetes drug XOMA-052
Read More
Valeant to acquire Dow Pharmaceutical Sciences for USD 285 million
Read More
IDMC recommends continuation of Seattle Genetics' phase IIb trial of lintuzumab in AML
Read More
Pharmacokinetic data for retigabine therapy disclosed
Read More
Nile presents results from phase Ib safety and PK study of CD-NP
Read More
Nuvelo reports encouraging results from phase I NU-206 trial in healthy volunteers
Read More
Phase III data show paliperidone's efficacy and tolerability in schizophrenia
Read More
PolyMedix announces positive phase I PMX-30063 data
Read More
ZymoGenetics reports favorable phase IIIb Recothrom results
Read More
Amylin, Lilly and Alkermes present update on DURATION clinical program for Byetta
Read More
FDA approves Pegintron/Rebetol combination in pediatric HCV patients
Read More
German regulatory authority approves CureVac's CTA to initiate phase I clinical study of CV-9103
Read More
SkyePharma and Somnus successfully complete phase I trial of SKP-1041 for sleep maintenance
Read More
Affiris initiates preclinical development of Parkinson's vaccine PD-01
Read More
Galmed successfully completes phase I trial of aramchol for fatty liver disease
Read More
Santhera completes recruitment into phase III MICONOS trial of SNT-MC17
Read More
Responses seen with afutuzumab in patients with CD20+ non-Hodgkin's lymphoma
Read More
TG-101348 appears well tolerated, decreases spleen size in myelofibrosis patients
Read More
Abraxis BioScience launches Abraxane in the European Union
Read More
Novel therapeutic agents for GERD disclosed in recent AstraZeneca patent
Read More
New antidiabetic agents disclosed in recent Merck Frosst patent
Read More
Recent Roche patent reports new agents for obesity
Read More
Rigel presents clinical data on fostamatinib disodium in B-cell NHL
Read More